The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Tau pathology in Alzheimer disease and other tauopathies
Open accessAbstract
Just as neuronal activity is essential to normal brain function, microtubule-associated protein tau appears to be critical to normal neuronal activity in the mammalian brain, especially in the evolutionary most advanced species, the homo sapiens. While the loss of functional tau can be compensated by the other two neuronal microtubule-associated proteins, MAP1A/MAP1B and MAP2, it is the dysfunctional, i.e., the toxic tau, which forces an affected neuron in a long and losing battle resulting in a slow but progressive retrograde neurodegeneration. It is this pathology which is characteristic of Alzheimer disease (AD) and other tauopathies. To date, the most established and the most compelling cause of dysfunctional tau in AD and other tauopathies is the abnormal hyperphosphorylation of tau. The abnormal hyperphosphorylation not only results in the loss of tau function of promoting assembly and stabilizing microtubules but also in a gain of a toxic function whereby the pathological tau sequesters normal tau, MAP1A/MAP1B and MAP2, and causes inhibition and disruption of microtubules. This toxic gain of function of the pathological tau appears to be solely due to its abnormal hyperphosphorylation because dephosphorylation converts it functionally into a normal-like state. The affected neurons battle the toxic tau both by continually synthesizing new normal tau and as well as by packaging the abnormally hyperphosphorylated tau into inert polymers, i.e., neurofibrillary tangles of paired helical filaments, twisted ribbons and straight filaments. Slowly but progressively, the affected neurons undergo a retrograde degeneration. The hyperphosphorylation of tau results both from an imbalance between the activities of tau kinases and tau phosphatases and as well as changes in tau's conformation which affect its interaction with these enzymes. A decrease in the activity of protein phosphatase-2A (PP-2A) in AD brain and certain missense mutations seen in frontotemporal dementia promotes the abnormal hyperphosphorylation of tau. Inhibition of this tau abnormality is one of the most promising therapeutic approaches to AD and other tauopathies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the several kinases involved in tau hyperphosphorylation (Singh et al., 1994;Johnson and Hartigan, 1999), CDK5 and GSK3 have been most implicated in the abnormal hyperphosphorylation of tau (Imahori and Uchida, 1997;Shelton and Johnson, 2004;Iqbal et al., 2005).”
From Retinoic Acid Attenuates β-Amyloid Deposition and Rescues Memory Deficits in an Alzheimer's Disease Transgenic Mouse Model (2008) · cites this paper as Iqbal et al., 2005
Citations
Cites
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
THE STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASES
Cohen, P. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.002321 · Cited by 2,543
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418 · cited 4×
“Tau in AD brain is abnormally hyperphosphorylated and in this state is the major protein subunit of PHF/SF which forms neurofibrillary tangles, a hallmark lesion of this disease [9–13].”
BackgroundInfluentialTau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M., Yu, X., et al. (2000) · Nature Genetics · doi:10.1038/78078 · Cited by 1,371
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321
Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., & Crowther, R. A. (1996) · Nature · doi:10.1038/383550a0 · Cited by 1,036
von Bergen, M., Friedhoff, P., Biernat, J., Heberle, J., Mandelkow, E.-M., & Mandelkow, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5129 · Cited by 1,021
Lucas, J. J., Hernández, F., Gómez‐Ramos, P., Morán, M. A., Hen, R., & Avila, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.27 · Cited by 913
Phosphorylation affects the ability of tau protein to promote microtubule assembly.
Lindwall, G., & Cole, R. D. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42989-9 · Cited by 901
Drewes, G., Ebneth, A., Preuss, U., Mandelkow, E.-M., & Mandelkow, E. (1997) · Cell · doi:10.1016/s0092-8674(00)80208-1 · Cited by 878
Alonso, A. D. C., Grundke-Iqbal, I., & Iqbal, K. (1996) · Nature Medicine · doi:10.1038/nm0796-783 · Cited by 859
Ubiquitin Is a Component of Paired Helical Filaments in Alzheimer's Disease
Mori, H., Kondo, J., & Ihara, Y. (1987) · Science · doi:10.1126/science.3029875 · Cited by 843
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831
Alonso, A. D. C., Zaidi, T., Novak, M., Grundke-Iqbal, I., & Iqbal, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121119298 · Cited by 827
Bancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., & Wisniewski, H. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91396-6 · Cited by 818
Altered microtubule organization in small-calibre axons of mice lacking tau protein
Harada, A., Oguchi, K., Okabe, S., Kuno, J., Terada, S., Ohshima, T., Sato-Yoshitake, R., Takei, Y., Noda, T., & Hirokawa, N. (1994) · Nature · doi:10.1038/369488a0 · Cited by 802
Köpke, E., Tung, Y. C., Shaikh, S., Alonso, A. C., Iqbal, K., & Grundke-Iqbal, I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80536-5 · Cited by 779
Self-citationO-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W., & Gong, C.-X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400348101 · Cited by 775
Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.
Alonso, A. C., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5562 · Cited by 738
DEFECTIVE BRAIN MICROTUBULE ASSEMBLY IN ALZHEIMER'S DISEASE
Iqbal, K., Zaidi, T., Wen, G. Y., Grundke, I., MERZ, P. A., Shaikh, S., Wisniewski, H., Alafuzoff, I. I., & Winblad, B. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92134-3 · Cited by 737
Tau protein and the neurofibrillary pathology of Alzheimer's disease
Goedert, M. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90078-z · Cited by 721
Perry, G., Friedman, R., Shaw, G., & Chau, V (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.3033 · Cited by 623
Cruz, J. C., Tseng, H.-C., Goldman, J. A., Shih, H., & Tsai, L.-H. (2003) · Neuron · doi:10.1016/s0896-6273(03)00627-5 · Cited by 609
Matsuo, E. S., Shin, R., Billingsley, M., de Voorde, A. V., O'Connor, M., Trojanowski, J., & Lee, V. (1994) · Neuron · doi:10.1016/0896-6273(94)90264-x · Cited by 588
A brain-specific activator of cyclin-dependent kinase 5
Lew, J., Huang, Q.-Q., Qi, R. Z., Winkfein, R. J., Aebersold, R. H., Hunt, T., & Wang, J. H.-C. (1994) · Nature · doi:10.1038/371423a0 · Cited by 580
Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state.
Drewes, G., Lichtenberg‐Kraag, B., Döring, F., Mandelkow, E. M., Biernat, J., Goris, J., Dorée, M., & Mandelkow, E. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05272.x · Cited by 565
Proline-directed and non-proline-directed phosphorylation of PHF-tau
Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Titani, K., & Ihara, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.823 · Cited by 557
Himmler, A., Drechsel, D. N., Kirschner, M. W., & Martin, D. W. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.4.1381-1388.1989 · Cited by 555
Kampers, T., Friedhoff, P., Biernat, J., Mandelkow, E.-M., & Mandelkow, E. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01386-5 · Cited by 548
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
Rissman, R. A., Poon, W. W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M. P., LaFerla, F. M., Rohn, T. T., & Cotman, C. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420640 · Cited by 543
Protein Phosphorylation and Neuronal Function
Browning, M. D., Huganir, R. L., & Greengard, P. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb05468.x · Cited by 528
Phosphoprotein Phosphatase Activities in Alzheimer Disease Brain
Gong, C., Singh, T. J., Grundke‐Iqbal, I., & Iqbal, K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03603.x · Cited by 527
Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo
Noble, W. J., Olm, V., Takata, K., Casey, E., Mary, O., Meyerson, J. L., Gaynor, K., LaFrancois, J. J., Wang, L., Kondo, T., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00259-9 · Cited by 511
DYNAMIC O-LINKED GLYCOSYLATION OF NUCLEAR AND CYTOSKELETAL PROTEINS
Hart, G. W. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.315 · Cited by 503
The Myeloid Leukemia-associated Protein SET Is a Potent Inhibitor of Protein Phosphatase 2A
Li, M., Makkinje, A., & Damuni, Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11059 · Cited by 479
Wille, H., Drewes, G., Biernat, J., Mandelkow�, E., & Mandelkow�, E. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.118.3.573 · Cited by 477
Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3
Hong, M., Chen, D. C. R., Klein, P. S., & Lee, V. M. ‐. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25326 · Cited by 476
Pei, J.-J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., & Cowburn, R. F. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199909000-00011 · Cited by 459
Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system
Tsai, L., Takahashi, T., Caviness, V. S., & Harlow, E. (1993) · Development · doi:10.1242/dev.119.4.1029 · Cited by 457
Phosphatase Activity Toward Abnormally Phosphorylated τ: Decrease in Alzheimer Disease Brain
Gong, C., Shaikh, S., Wang, J., Zaidi, T., Grundke, I., & Iqbal, K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020732.x · Cited by 440
Alonso, A. D. C., Grundke-Iqbal, I., Barra, H. S., & Iqbal, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.298 · Cited by 437
[37] Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle
Cohen, P., Alemany, S., Therese, B. A., Resink, J., Strålfors, P., & Tung, H. Y. L. (1988) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(88)59039-0 · Cited by 411
Grundke, I., Iqbal, K., Tung, Y.-C., Quinlan, M., Wisniewski, H., & Binder, L. (1987) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198701030-00020 · Cited by 410
Defects in Axonal Elongation and Neuronal Migration in Mice with Disrupted tau and map1b Genes
Takei, Y., Teng, J., Harada, A., & Hirokawa, N. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.5.989 · Cited by 408
Gong, C.-X., Lidsky, T., Wegiel, J., Zuck, L., Grundke-Iqbal, I., & Iqbal, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5535 · Cited by 405
Lindern, M. V., van Baal, S., Wiegant, J. C. A. G., Raap, A. K., Hagemeijer, A., & Grosveld, G. C. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.8.3346 · Cited by 392
Microtubule-associated Protein/Microtubule Affinity-regulating Kinase (p110mark)
Meyer, H. E., Mandelkow, E.-M., Drewes, G., Trinczek, B., Illenberger, S., Biernat, J., Schmitt-Ulms, G., & Mandelkow, E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7679 · Cited by 388
Hanger, D. P., Betts, J. C., Loviny, T. L. F., Blackstock, W. P., & Anderton, B. H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062465.x · Cited by 386
Calpain-dependent Proteolytic Cleavage of the p35 Cyclin-dependent Kinase 5 Activator to p25
Kusakawa, G.-I., Saito, T., Onuki, R., Ishiguro, K., Kishimoto, T., & Hisanaga, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m907757199 · Cited by 381
Schweers, O., Mandelkow, E., Biernat, J., & Mandelkow, E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8463 · Cited by 379
Neurons May Live for Decades with Neurofibrillary Tangles
Morsch, R., Simon, W., & Coleman, P. D. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199902000-00008 · Cited by 370
Sengupta, A., Kabat, J., Novak, M., Wu, Q., Grundke-Iqbal, I., & Iqbal, K. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0813 · Cited by 363
The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine
Arnold, C. S., Johnson, G. W., Cole, R. N., Dong, D. L.-Y., Lee, M., & Hart, G. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28741 · Cited by 361
Wang, J.-Z., Grundke-Iqbal, I., & Iqbal, K. (1996) · Nature Medicine · doi:10.1038/nm0896-871 · Cited by 360
Aberrant neurofilament phosphorylation in Alzheimer disease.
Sternberger, N. H., Sternberger, L. A., & ULRICH, J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4274 · Cited by 338
Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations
Alonso, A. D. C., Mederlyova, A., Novák, M., Grundke, I., & Iqbal, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405131200 · Cited by 330
Spittaels, K., den Haute, C. V., Dorpe, J. V., Geerts, H., Mercken, M. H., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006219200 · Cited by 324
Teng, J., Takei, Y., Harada, A., Nakata, T., Chen, J., & Hirokawa, N. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200106025 · Cited by 315
An, W.-L., Cowburn, R. F., Li, L., Braak, H., Alafuzoff, I., Iqbal, K., Iqbal, I.-G., Winblad, B., & Pei, J.-J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63687-5 · Cited by 312
Steiner, B., Mandelkow�, E., Biernat, J., Gustke, N., Meyer, H. E., Schmidt, B., Mieskes, G., Söling, H., Drechsel, D. N., & Kirschner, M. W. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07563.x · Cited by 304
Khatoon, S., Grundke, I., & Iqbal, K. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09432.x · Cited by 304
Duff, K., Knight, H., Refolo, L. M., Sanders, S., Yu, X., Picciano, M., Malester, B., Hutton, M., Adamson, J., Goedert, M., et al. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0279 · Cited by 269
Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B
Wang, J.-Z., Gong, C.-X., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4854 · Cited by 269
Glycogen Synthase Kinase 3β Phosphorylates Tau at Both Primed and Unprimed Sites
Cho, J.-H., & Johnson, G. V. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206236200 · Cited by 266
Alafuzoff, I. I., Iqbal, K., Fridén, H., Adolfsson, R., & Winblad, B. G. (1987) · Acta Neuropathologica · doi:10.1007/bf00688184 · Cited by 265
Jicha, G. A., Lane, E., Vincent, I. J., Ötvös, L., Hoffmann, R., & Davies, P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052087.x · Cited by 264
Wagner, U., Utton, M. A., Gallo, J., & Miller, C. C. J. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.6.1537 · Cited by 258
Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease.
Iqbal, K., Grundke, I., Smith, A. J., George, L., Tung, Y. C., & Zaidi, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5646 · Cited by 256
Li, M., Guo, H., & Damuni, Z. (1995) · Biochemistry · doi:10.1021/bi00006a020 · Cited by 229
Pei, J.-J., Grundke-Iqbal, I., Iqbal, K., Bogdanovic, N., Winblad, B., & Cowburn, R. F. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00296-0 · Cited by 226
Novák, M., Jakes, R., Edwards, P. C., Milstein, C., & Wischik, C. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5837 · Cited by 219
Scott, C. W., Spreen, R. C., Herman, J. L., Chow, F. P., Davison, M. D., Young, J., & Caputo, C. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54055-2 · Cited by 202
Lovestone, S., Hartley, C. L., Pearce, J., & Anderton, B. H. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00126-1 · Cited by 201
Wang, J.-Z., Wu, Q., Smith, A., Grundke, I., & Iqbal, K. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01090-4 · Cited by 199
Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK‐3β
Liu, F., Iqbal, K., Grundke, I., & Gong, C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03487-7 · Cited by 197
Fasulo, L., Ugolini, G., Visintin, M., Bradbury, A. M., Brancolini, C., Verzillo, V., Novák, M., & Cattaneo, A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750624.x · Cited by 195
Physiologic importance of protein phosphatase inhibitors
Shenolikar, S. (1998) · Frontiers in bioscience · doi:10.2741/a336 · Cited by 194
Ledesma, M. D., Correas, I., Ávila, J., & Díaz‐Nido, J. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81278-t · Cited by 190
Bancher, C., Grundke, I., Iqbal, K., Fried, V. A., Smith, H. T., & Wisniewski, H. M. (1991) · Brain Research · doi:10.1016/0006-8993(91)90681-k · Cited by 185
Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model
Pérez, M., Hernández, F., Lim, F., Díaz‐Nido, J., & Ávila, J. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5405 · Cited by 180
Li, M., Makkinje, A., & Damuni, Z. (1996) · Biochemistry · doi:10.1021/bi960581y · Cited by 178
Mitotic phosphoepitopes precede paired helical filaments in Alzheimer’s disease
Vincent, I. J., Zheng, J.-H., Dickson, D. W., Kress, Y., & Davies, P. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00071-2 · Cited by 176
Structure of tau protein and assembly into paired helical filaments
Friedhoff, P., von Bergen�, M., Mandelkow, E., & Mandelkow, E. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00038-7 · Cited by 172
Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease
Liu, F., Zaidi, T., Iqbal, K., Grundke-Iqbal, I., Merkle, R. K., & Gong, C.-X. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02228-7 · Cited by 167
Crowther, R. A., Olesen, O. F., Jakes, R., & Goedert, M. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81094-3 · Cited by 167
Pei, J.-J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., & Cowburn, R. F. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3107 · Cited by 165
Self-citationPotentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5
Sengupta, A., Wu, Q., Grundke, I., Iqbal, K., & Singh, T. J. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006883924775 · Cited by 160
Alonso, A. D. C., Zaidi, T., Novák, M., Barra, H. S., Grundke, I., & Iqbal, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105365200 · Cited by 160
Kins, S., Kurosinski, P., Nitsch, R. M., & Götz, J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63444-x · Cited by 155
Tau Protein in Normal and Alzheimer's Disease Brain: An Update
Johnson, G. V. W., & Hartigan, J. A. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-14-512 · Cited by 154
Wang, J., Grundke, I., & Iqbal, K. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00316-k · Cited by 154
Li, L., Sengupta, A., Haque, N., Grundke, I., & Iqbal, K. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.047 · Cited by 154
Litersky, J. M., Johnson, G. V. W., Jakes, R., Goedert, M., Lee, M., & Seubert, P. A. (1996) · Biochemical Journal · doi:10.1042/bj3160655 · Cited by 150
Alzheimer paired helical filaments Restoration of the biological activity by dephosphorylation
Iqbal, K., Zaidi, T., Bancher, C., & Grundke, I. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00650-4 · Cited by 150
Calpain-mediated Cleavage of the Cyclin-dependent Kinase-5 Activator p39 to p29
Patzke, H., & Tsai, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109645200 · Cited by 147
Pei, J.-J., Gong, C., An, W., Winblad, B. G., Cowburn, R. F., Grundke, I., & Iqbal, K. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63445-1 · Cited by 142
Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau.
Tanemura, K., Akagi, T., Murayama, M., Kikuchi, N., Murayama, O., Hashikawa, T., Yoshiike, Y., Park, J.-M., Matsuda, K., Nakao, S., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0439 · Cited by 141
Protein phosphorylation and neuronal function.
Walaas, S. I., & Greengard, P. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06666-9 · Cited by 137
Wang, J., Tung, Y. C., Wang, Y., Li, X., Iqbal, K., & Grundke, I. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02944-1 · Cited by 133
Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments
Grundke, I., VORBRODT, A. W., Iqbal, K., Tung, Y. C., Wang, G. P., & Wisniewski, H. M. (1988) · Molecular Brain Research · doi:10.1016/0169-328x(88)90017-4 · Cited by 128
Jicha, G. A., Berenfeld, B., & Davies, P. J. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6 · Cited by 119
Polymerization of tau peptides into fibrillar structures. The effect of FTDP‐17 mutations
Arrasate, M., Pérez, M., Armas-Portela, R., & Ávila, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00210-0 · Cited by 118
Pérez, M., Cuadros, R., Smith, M. A., Perry, G. L., & Ávila, J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02323-1 · Cited by 116
Tau Protein and the Neurofibrillary Pathology of Alzheimer's Disease
Goedert, M. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34410.x · Cited by 115
The regulation of phosphorylation of τ in SY5Y neuroblastoma cells: the role of protein phosphatases
Tanaka, T., Zhong, J., Iqbal, K., Trenkner, E., & Grundke, I. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00346-9 · Cited by 113
de Garcini, E. M., Serrano, L. G., & Ávila, J. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80242-x · Cited by 112
Brain Protein Kinase PK40erk Converts TAU into a PHF-like Form as Found in Alzheimer′s Disease
Roder, H. M., Eden, P. A., & Ingram, V. M. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1672 · Cited by 110
Bennecib, M., Gong, C., Grundke, I., & Iqbal, K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02127-5 · Cited by 109
Hasegawa, M., Arai, T., & Ihara, Y. (1990) · Neuron · doi:10.1016/0896-6273(90)90144-5 · Cited by 107
Liu, F., Zaidi, T., Iqbal, K., Grundke, I., & Gong, C. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00510-9 · Cited by 106
Role of tau phosphorylation by glycogen synthase kinase-3β in the regulation of organelle transport
Tatebayashi, Y., Haque, N., Tung, Y. C., Iqbal, K., & Grundke, I. (2004) · Journal of Cell Science · doi:10.1242/jcs.01018 · Cited by 104
Sites of phosphorylation in tau and factors affecting their regulation
Anderton, B. H., Betts, J. C., Blackstock, W. P., Brion, J., Chapman, S., Connell, J. W., Dayanandan, R., Gallo, J., Gibb, G., Hanger, D. P., et al. (2001) · Biochemical Society Symposia · doi:10.1042/bss0670073 · Cited by 99
Functional studies of Alzheimer's disease tau protein
Lu, Q., & Jg, W. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00508.1993 · Cited by 96
Brandt, R., Lee, G. S., Teplow, D. B., Shalloway, D. I., & Abdel-Ghany, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32639-x · Cited by 90
Singh, T. J., Zaidi, T., Grundke, I., & Iqbal, K. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01383-c · Cited by 86
Phosphorylation of τ Protein by Casein Kinase‐1 Converts It to an Abnormal Alzheimer‐Like State
Singh, T. J., Grundke, I., & Iqbal, K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64031420.x · Cited by 83
Singh, T. J., Wang, J., Novák, M., Kontzekova, E., Grundke, I., & Iqbal, K. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00485-1 · Cited by 82
Polymerization of Microtubule-associated Protein Tau under Near-physiological Conditions
Wilson, D. M., & Binder, L. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24306 · Cited by 81
Garver, T. D., Harris, K. A., Lehman, R. A. W., Lee, V., Trojanowski, J., & Billingsley, M. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062279.x · Cited by 80
Sironi, J., Yen, S.-H. C., Gondal, J. A., Wu, Q., Grundke, I., & Iqbal, K. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01185-5 · Cited by 75
Ulloa, L., de Garcini, E. M., Gómez‐Ramos, P., Morán, M. A., & Ávila, J. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90081-7 · Cited by 69
The microtubule-associated protein tau forms a triple-stranded left-hand helical polymer.
Ruben, G. C., Iqbal, K., Grundke, I., Wisniewski, H. M., Ciardelli, T. L., & Johnson, J. E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54739-6 · Cited by 67
Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach
Iqbal, K., del Alonso, A. C., Gondal, J. A., Gong, C., Haque, N., Khatoon, S., Sengupta, A., Wang, J.-Z., & Grundke, I. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_22 · Cited by 60
Biochemical Characterization Of Mapmodulin, a Protein That Binds Microtubule-associated Proteins
Ulitzur, N., Rancaño, C., & Pfeffer, S. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30577 · Cited by 54
Singh, J., Grundke, I., McDonald, B., & Iqbal, K. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00925955 · Cited by 53
Singh, T. J., Zaidi, T., Grundke, I., & Iqbal, K. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00226782 · Cited by 51
Folding of Alzheimer's core PHF subunit revealed by monoclonal antibody 423
Škrabana, R., KONTSEK, P., Mederlyova, A., Iqbal, K., & Novák, M. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.098 · Cited by 46
Altered conformation of recombinant frontotemporal dementia-17 mutant tau proteins.
Jicha, G. A., Rockwood, J. M., Berenfeld, B., Hutton, M., & Davies, P. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00980-x · Cited by 44
Iqbal, K., & Grundke, I. (2004) · Current Drug Targets · doi:10.2174/1389450043345254 · Cited by 35
Yanagawa, H., Chung, S.-H., Ogawa, Y., Sato, K., Shibata‐Seki, T., Masai, J., & Ishiguro, K. (1998) · Biochemistry · doi:10.1021/bi9724265 · Cited by 34
Ruben, G. C., Iqbal, K., Wisniewski, H. M., Johnson, J. E., & Grundke, I. (1992) · Brain Research · doi:10.1016/0006-8993(92)91092-s · Cited by 32
Singh, T. J., Grundke‐Iqbal, I., & Iqbal, K. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0140 · Cited by 32
Singh, T. J., Grundke, I., Wu, W. Q., Chauhan, V. P. S., Novák, M., Kontzekova, E., & Iqbal, K. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006807105059 · Cited by 30
Alzheimer's disease and related disorders: research advances
Checler, F., & Petit-Paitel, A. (2003) · HAL (Le Centre pour la Communication Scientifique Directe) · Cited by 30
A pool of β‐tubulin is hyperphosphorylated at serine residues in Alzheimer disease brain
Vijayan, S., El-Akkad, E., Grundke, I., & Iqbal, K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03201-x · Cited by 27
Molecular Neurobiology of Alzheimer Disease and Related Disorders
Takeda, M. 1. (2004) · KARGER eBooks · doi:10.1159/isbn.978-3-318-00993-4 · Cited by 22
Cheng, L. Y., Wang, J., Gong, C., Pei, J.-J., Zaidi, T., Grundke, I., & Iqbal, K. (2001) · Neurochemical Research · doi:10.1023/a:1010963401453 · Cited by 16
Cheng, L. Y., Wang, J., Gong, C., Pei, J.-J., Zaidi, T., Grundke, I., & Iqbal, K. (2000) · Neurochemical Research · doi:10.1023/a:1007547701518 · Cited by 14
Pivotal Role of Neurofibrillary Degeneration in Alzheimer Disease and Therapeutic Targets
Iqbal, K., Alonso, A. D. C., El-Akkad, E., Gong, C.-X., Haque, N., Khatoon, S., Tanimukai, H., Tsujio, I., & Grundke, I. (2004) · KARGER eBooks · doi:10.1159/000078525 · Cited by 2
P2-034 Cognitive deficit and progressive motor impairment in AD rat model
Hrnkova, M., Žilka, N., Filipčík, P., & Novák, M. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(04)80782-6 · Cited by 1
Winblad (1999) · doi:10.1002/(sici)1099-1166(199902)14:2
Cited by
Sorted by citations
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863
Metadata
- Authors
- Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., Tanimukai, H., & Grundke-Iqbal, I.
- Affiliations
- New York State Office for People With Developmental Disabilities (US)
- Corresponding author
- Iqbal, Khalid
- ORCID
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 1739
- Issue
- 2-3
- Pages
- 198-210
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W1998440070
- Cited by
- 1,037
- References
- 154
- Citations by year
- 2026: 28 · 2025: 48 · 2024: 50 · 2023: 67 · 2022: 60 · 2021: 60 · 2020: 57 · 2019: 58 · 2018: 64 · 2017: 48 · 2016: 48 · 2015: 54 · 2014: 52 · 2013: 48 · 2012: 52
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG19158, R01AG019158)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, tauopathy, Alzheimer's disease, tau hyperphosphorylation, neurofibrillary tangles, paired helical filaments, microtubule stabilization, MAP2, tau kinases, protein phosphatase 2A, frontotemporal dementia, tau conformation, neurodegeneration, tau dephosphorylation, tau-targeted therapy
- MeSH terms
- Alzheimer Disease, Brain, Enzyme Inhibitors, Humans, Models, Biological, Nerve Degeneration, Neurofibrils, Phosphoprotein Phosphatases, Phosphorylation, Protein Conformation, Protein Kinases, Neurofibrillary Tangles, tau Proteins, Tauopathies, Protein Phosphatase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review